City

Buffalo (1)

Hamilton (1)

Rochester (1)

Toronto (1)

Vancouver (1)

Overall Status

Completed (3)

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Amgen (1)

National Cancer Institute (NCI) (1)

Roswell Park Cancer Institute (1)

Collaborator

Amgen (1)

Intervention

trebananib (3)

laboratory biomarker analysis (2)

pharmacological study (2)

cytarabine (1)

sunitinib (1)

temsirolimus (1)

Study Documents

Intervention Type

drug (3)

biological (2)

other (2)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (3)

trebananib

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed

Adult Acute Megakaryoblastic Leukemia (M7)
+15 more

trebananib
+3 more

Buffalo, New York
+1 more

Sep 8, 2022

Advanced Renal Cell Carcinoma Trial (Sunitinib, Trebananib)

Completed

Has Results

Advanced Renal Cell Carcinoma

Sunitinib
Trebananib

(no location specified)

Jun 10, 2020

Adult Solid Tumor, Lung Carcinoid Tumor, Recurrent Digestive System Neuroendocrine Tumor G1 Trial in Vancouver, Hamilton,

Completed

Adult Solid Neoplasm
+10 more

Laboratory Biomarker Analysis
+3 more

Vancouver, British Columbia, Canada
+2 more

Oct 5, 2015